Evidence map›Paper›PMID 40420507›Full record

ArticleBrain pathology (Zurich, Switzerland)2025

cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classification.

Cynthia Hawkins, Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R Gilbert, Thomas S Jacques, David Jones, Takashi Komori, David N Louis and 12 more

Abstract readLetter
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. "Updates on diagnostic and prognostic molecular biomarkers of CNS tumors".Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  3. Review
  4. Article
  5. A brief history of ependymoma.Neuro-oncology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Cynthia HawkinsDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-2618-4402
Kenneth AldapeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
David CapperDepartment of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Andreas von DeimlingDepartment of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
Caterina GianniniDepartment of Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Mark R GilbertNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Thomas S JacquesUCL GOS Institute of Child Health and Department of Histopathology, Great Ormond Street Hospital for Children, London, UK.
David JonesDivision of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Takashi KomoriDepartment of Laboratory Medicine and Pathology (Neuropathology), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
David N LouisDepartment of Pathology, Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-9423-4099
Sabine MuellerDepartment of Neurology, Neurosurgery, and Pediatrics, University of California San Francisco, San Francisco, California, USA.
MacLean NasrallahDivision of Neuropathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-4861-0898
Brent A OrrDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID https://orcid.org/0000-0003-0997-4728
Arie PerryDepartment of Pathology, University of California San Francisco, San Francisco, California, USA.
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Felix SahmDepartment of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
Chitra SarkarDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-4315-9316
Matija SnuderlDepartment of Pathology, New York University Langone Health and Grossman School of Medicine, New York, New York, USA.
David SolomonDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.ORCID https://orcid.org/0000-0003-4571-7999
Pascale VarletDepartment of Neuropathology, GHU Paris-Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France.
Pieter WesselingDepartment of Pathology, Amsterdam University Medical Centers/VU University, Amsterdam, The Netherlands.
Guido ReifenbergerDepartment of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Funding

NIHR Great Ormond Street Hospital Biomedical Research Centre
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40420507
PMCPMC12488253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.